Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Proton Radiotherapy and Chemotherapy in Esophageal Cancer
NCT02213497Phase 1Active, not recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Apr 2014
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in esophageal cancer, sponsored by Abramson Cancer Center. Primary endpoint: Number of Adverse Events at 3 years. Started Apr 2014; status: active, not recruiting.
02
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02213497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213497.